Catumaxomab (anti-CD3&EpCAM), a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab (anti-CD3&EpCAM) region has binding